Managing the intersection of cancer therapies and cardiovascular health, cardio-oncology has become an essential focus for healthcare providers. Treatments like chemotherapy and immunotherapy, while critical for combating cancer, can strain the heart and lead to conditions such as cardiomyopathy or arrhythmias. To address this, specialists collaborate to develop screening tools that predict risks and implement heart-protective strategies. Imaging techniques, advanced echocardiography, and biomarkers enable early detection of cardiotoxicity, ensuring timely interventions. By prioritizing the balance between effective cancer treatment and heart health, cardio-oncology aims to safeguard patients' quality of life during and beyond their cancer journey.
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of life, the skinny on novel lipid therapies beyond statins
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Movement is medicine
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Analysis of cardiovascular risk factors in patients with type 1 diabetes mellitus
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Beyond PCSK9: The next wave of lipid-lowering and thrombosis prevention - from bench to breakthrough
Narendra Kumar, HeartbeatsZ Academy, United Kingdom